Evidence map›Paper›PMID 36235651›Full record

Trial reportNutrients2022

Potential Modulation of Inflammation by Probiotic and Omega-3 Supplementation in Elderly with Chronic Low-Grade Inflammation-A Randomized, Placebo-Controlled Trial.

Lina Tingö, Ashley N Hutchinson, Cecilia Bergh, Lena Stiefvatter, Anna Schweinlin, Morten G Jensen, Kirsten Krüger, Stephan C Bischoff, Robert J Brummer

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Lina TingöNutrition-Gut-Brain Interactions Research Centre, School of Medical Sciences, Örebro University, 70362 Örebro, Sweden.ORCID 0000-0002-2482-9281
Ashley N HutchinsonNutrition-Gut-Brain Interactions Research Centre, School of Medical Sciences, Örebro University, 70362 Örebro, Sweden.
Cecilia BerghClinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, 70362 Örebro, Sweden.ORCID 0000-0002-0853-7545
Lena StiefvatterDepartment of Nutritional Medicine and Prevention, University of Hohenheim, 70599 Stuttgart, Germany.ORCID 0000-0002-6767-4101
Anna SchweinlinDepartment of Nutritional Medicine and Prevention, University of Hohenheim, 70599 Stuttgart, Germany.ORCID 0000-0002-1752-1924
Morten G JensenGSK Consumer Healthcare ApS, 2665 Vallensbæk Strand, Denmark.
Kirsten KrügerHuman Nutrition & Health, Department of Agrotechnology and Food Sciences, Wageningen University & Research, 9101 Wageningen, The Netherlands.ORCID 0000-0003-2963-6099
Stephan C BischoffDepartment of Nutritional Medicine and Prevention, University of Hohenheim, 70599 Stuttgart, Germany.ORCID 0000-0003-2614-5948
Robert J BrummerNutrition-Gut-Brain Interactions Research Centre, School of Medical Sciences, Örebro University, 70362 Örebro, Sweden.ORCID 0000-0002-0362-0008
Örebro University · SEUniversity of Hohenheim · DELinköping University · SEWageningen University & Research · NL

Funding

Pfizer Consumer Healthcare not applicable
6 · The paper itself

Abstract

Probiotic and omega-3 supplements have been shown to reduce inflammation, and dual supplementation may have synergistic health effects. We investigated if the novel combination of a multi-strain probiotic (containing

Indexed as

Fatty Acids, Omega-3ProbioticsAgedC-Reactive ProteinDietary SupplementsDouble-Blind MethodHumansInflammationInterleukin-10C-Reactive ProteinFatty Acids, Omega-3Interleukin-10chronic low-grade inflammationelderlyhs-CRPn-3 PUFAomega-3probioticsRCTshort-chain fatty acids

Identifiers

PMID36235651
PMCPMC9573426
OpenAlexW4297547842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.